Ralfinamide

Known as: Priralfinamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
0120042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Neuropathic pain is among the most common and difficult-to-treat types of chronic pain and is associated with sodium channel… (More)
Is this relevant?
2012
2012
Ralfinamide, an original Na+ channel blocker developed for the treatment of chronic pain, inhibits monoamineoxidase-B with no… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
Ralfinamide is an α-aminoamide derivative with ion channel blocking properties, acting both peripherally and centrally through… (More)
Is this relevant?
2008
2008
Ralfinamide is analgesic when applied as a single dose in rodent models of stimulus-evoked chronic pain. However, it is unknown… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Recent studies revealed that ralfinamide, a Na(+) channel blocker, suppressed tetrodotoxin-resistant Na(+) currents in dorsal… (More)
Is this relevant?
2005
2005
Tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ channels contribute to the abnormal spontaneous firing in dorsal root… (More)
Is this relevant?
2004
2004
 
Is this relevant?